To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
ExisulindExisulind is a drug used to treat cancer. It acts by inhibiting the enzyme cyclic guanosine monophosphate phosphodiesterase. Tademark by OSI Pharmaceuticals is Aptosyn. |
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Exisulind". A list of authors is available in Wikipedia. |
Last viewed
- Journal_of_Chemical_Information_and_Modeling
- Integration of Ciba: BASF specifies restructuring plans - 23 of 55 acquired production sites worldwide under review
- Cadiot-Chodkiewicz_coupling
- Scott Bader Joins New UK Project Group To Discover Alternative Composites Production
- Scientists stabilize atomically thin boron for practical use - Borophane is stable outside a vacuum, opening possibilities for real-world applications
